Document:

SEPARATION
AND RELEASE AGREEMENT

 

This
Agreement (this “Agreement”) is made as of September 26, 2019, by and between DIGIPATH, INC., a Nevada corporation
(the “Company”), and TODD DENKIN (“Denkin”).

 

RECITALS

 

WHEREAS,
Denkin and the Company are parties to an Amended and Restated Employment Agreement dated as of June 21, 2016, as amended by an
Amendment to Employment Agreement dated December 22, 2017 (as so amended, the “Employment Agreement”), pursuant to
which Denkin is employed as the Company’s President and Chief Executive Officer; and

 

WHEREAS,
the Company and Denkin have agreed to a termination of the Employment Agreement and their relationship on the terms set forth
herein.

 

NOW,
THEREFORE, THE PARTIES AGREE AS FOLLOWS:

 

1.
Termination of Employment Relationship; Resignation as Officer and Director. Effective as of September 26, 2019 (the “Effective
Date”), without any further action of the parties hereto, Denkin shall cease to be a director, officer and/or employee of
the Company and each of its subsidiaries.

 

2.
Payments and Consulting Services.

 

(a)
The Company shall pay Denkin a lump sum severance payment in the amount of $20,000 concurrently with the execution of this Agreement
(the “Severance Payment”). In addition, for the three-month period beginning on the date hereof (the “Consulting
Period”), Denkin shall consult with the Company during regular business hours to assist the Company in the transition of
its next Chief Executive Officer, and in consideration therefor shall be paid consulting fees in the amount of $6,000 per month,
payable in periodic installments in accordance with the Company’s regular practices.

 

(b)
The Company shall cause to be transferred to Denkin, at no additional cost to him, the https://thenationalmarijuananews.com/
domain name and related URLs, and content therein. Denkin shall also have the right to use and retain copies of the “The
Marijuana Industry” Lecture Materials prepared by the Company and Medicus Research (the “Medicus Materials”),
including, without limitation, unlimited rights to use the Medicus Materials in any media (television, film, internet, pay-per-view,
digital and other media now known or learned), and the ability to assign or license the Medicus Materials to others. The Company
shall execute all instruments of transfer reasonably requested by Denkin to carry out the provisions of this Section 2(b).

 

(c)
All references herein to compensation to be paid to Denkin are to the gross amounts thereof which are due hereunder. The Company
shall have the right to deduct therefrom all taxes which may be required to be deducted or withheld by applicable law.

 

    	 	1	 

    	 

    

 

3.
Release.

 

(a)
In exchange for the consideration provided for by Section 2 hereof, Denkin for himself and for his heirs, executors, administrators
and assigns (hereinafter referred to collectively as “Releasors”), forever releases and discharges the Company, Digipath
Labs, Inc., GroSciences, Inc. and all other now or hereafter existing subsidiaries, parent companies, divisions, affiliates or
related business entities, successors and assigns of the Company, and any of their past or present shareholders, directors, officers,
attorneys, agents, trustees, administrators, employees or assigns (whether acting as agents for the Company or in their individual
capacities) (hereinafter referred to collectively as “Releasees”), from any and all claims, demands, causes of action,
fees and liabilities of any kind whatsoever, whether known or unknown, which Releasors ever had, now have or may have against
Releasees by reason of any actual or alleged act, omission, transaction, practice, conduct, occurrence or other matter up to and
including the date hereof.

 

(b)
Without limiting the generality of the foregoing, this Agreement is intended to and shall release Releasees from any and all claims,
whether known or unknown (but excluding any claims or rights that Denkin may have as a stockholder of the Company or under COBRA),
which Releasors ever had, now have and may have against Releasees, including but not limited to any claims, whether or not asserted,
arising out of Denkin’s employment with Releasees and/or his termination from such employment, including but not limited
to: (i) any claim under the Civil Rights Act of 1964, as amended; (ii) any other claim of discrimination or retaliation in
employment (whether based on federal, state or local law, statutory or decisional); (iii) any claim arising out of the terms and
conditions of Denkin’s employment with the Company, his termination from such employment, and/or any of the events relating
directly or indirectly to or surrounding such termination; (iv) any claim of discrimination or breach of fiduciary duty under
the Employee Retirement Income Security Act of 1974, as amended (except claims for accrued vested benefits under any employee
benefit plan of the Company in accordance with the terms of such plan and applicable law); (v) any claim arising under the Federal
Age Discrimination in Employment Act of 1997, as amended, and the applicable rules and regulations thereunder; and (vi) any claim
for attorney’s fees, costs, disbursements and/or the like.

 

4.
Covenant not to Sue. Denkin covenants, except to the extent prohibited by law, not to commence, maintain, prosecute or
participate in any action, charge, complaint or proceeding of any kind (on their own behalf and/or on behalf of any other person
or entity and/or on behalf of or as a member of any alleged class of persons) in any court, or before any administrative or investigative
body or agency (whether public, quasi-public or private), except if otherwise required by law, against Releasees with respect
to any act, omission, transaction or occurrence up to and including the date on which this Agreement is executed.

 

    	 	2	 

    	 

    

 

5.
Non-Disparagement. Denkin agrees that he will not at any time, orally or in writing, willfully denigrate, disparage, ridicule
or criticize, or willfully make any derogatory, disparaging or damaging statements (or induce or encourage others to engage in
any such act) regarding the Company or any of its subsidiaries, divisions, affiliates or related business entities, successors
and assigns or any of their past or present directors, officers, attorneys, agents, trustees, administrators, employees, consultants
or any other representatives of the Company, or any of their products or services, including by way of news interviews or the
expression of personal views, opinions or judgments to the media. Disparaging remarks include, without limitation, comments or
statements that impugn the character, honesty, integrity, morality or business acumen or abilities of the individual or entity
being disparaged.

 

6.
Continuing Obligations, including Confidentiality; Return of Company Property, and Non-Solicitation. Following the date
hereof, Denkin shall continue to be bound by the provisions of Section 8 of the Employment Agreement in accordance with the terms
thereof.

 

7.
Cooperation. Denkin agrees to cooperate with the Company and its counsel in any action, proceeding or litigation relating
to any matter in which Denkin was involved or of which Denkin has knowledge as a result of or in connection with his service to
the Company.

 

8.
Acknowledgment. Denkin acknowledges that he: (i) has carefully read this Agreement in its entirety; (ii) has had an opportunity
to consider fully the terms of this Agreement; (iii) fully understands the significance of all the terms and conditions of this
Agreement; (v) has had answered to his satisfaction any questions he has asked with regard to the meaning and significance of
any of the provisions of this Agreement; and (v) is signing this Agreement voluntarily and of his own free will and assents to
all the terms and conditions contained herein.

 

9.
Specific Performance. In view of the irreparable harm and damage which would be incurred by the Company in the event of
any violation by Denkin of any of the provisions of Sections 4 through 7 hereof, Denkin hereby consents and agrees that in any
such event, in addition to any other rights the Company may have, and without prejudice to any other remedies which may be available
at law or in equity, the Company shall be entitled to an injunction or similar equitable relief to be issued by any court of competent
jurisdiction restraining Denkin from committing or continuing any such violation, without the necessity of proving damage, or
posting any bond or other security.

 

10.
Governing Law. This Agreement shall be governed in all respects by the laws of the State of Nevada without reference to
its choice of law rules.

 

11.
Successors and Assigns. Except as otherwise provided herein, the provisions hereof shall inure to the benefit of, and be
binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto.

 

12.
Entire Agreement; Amendment. This Agreement constitutes the full and entire understanding and agreement between the parties
with regard to the subjects hereof. Neither this Agreement nor any term hereof may be amended, waived, discharged or terminated
other than by a written instrument signed by the party to be charged.

 

13.
Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be enforceable against
the parties actually executing such counterparts, and all of which together shall constitute one instrument.

 

14.
Severability. The holding of any provision of this Agreement to be invalid or unenforceable by a court of competent jurisdiction
shall not affect any other provision of this Agreement, which shall remain in full force and effect.

 

    	 	3	 

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day and year first above written.

 

	 	DIGIPATH,
    INC.
	 	 
	 	By	/s/
    Todd Peterson
	 	Name:	Todd
    Peterson
	 	Title:	Chief
    Financial Officer
	 	 	 
	 	/s/ Todd Denkin
	 	Todd Denkin

 

    	 	4EMPLOYMENT
AGREEMENT

 

EMPLOYMENT
AGREEMENT (this “Agreement”), dated as of September 25, 2019 (the “Effective Date”),
by and between DIGIPATH, INC., a Nevada corporation with its principal place of business at 6450 Cameron Street, Suite 113, Las
Vegas, NV 89014 (the “Company”) and KYLE REMENDA, an individual
residing at 2532 Shoreline Drive, Lake Country BC, V4V2R6 Canada (“Executive”).

 

W
I T N E S S E T H

 

WHEREAS,
the Company desires to employ Executive, and Executive desires to be employed by the Company, subject to the terms and conditions
set forth below.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual agreements and covenants hereinafter set forth, the parties hereto
agree as follows:

 

1.
Employment. The Company hereby employs Executive and Executive hereby accepts employment by the Company for the period
and on the terms and conditions set forth in this Agreement.

 

2.
Position, Employment Duties and Responsibilities. Executive shall be employed as the Company’s Chief Executive Officer,
and in such capacity shall have responsibility for the overall operations of the Company and its subsidiaries, and such other
duties and responsibilities customarily associated with such position or reasonably imposed by the Company’s Board of Directors
(the “Board”), and subject to the Company’s company policies and procedures. Throughout the term of this
Agreement, Executive shall devote his entire working time to the performance of his duties hereunder in a manner which will faithfully
and diligently further the business and interests of the Company.

 

3.
Working Facilities. Executive will work remotely from British Colombia, Canada until such time as he shall have obtained
the requisite documentation and visa to be legally employed in the United States (collectively, “US Visa”), and shall
thereafter work out of offices of the Company located in Las Vegas, Nevada. The Executive shall use his best efforts to obtain
a US Visa as soon as practicable.

 

4.
Compensation and Benefits.

 

4.1
Base Salary. For all of the services rendered by Executive to the Company, the Company shall pay to Executive an annual
base salary of one hundred sixty thousand dollars ($160,000), payable in reasonable periodic installments in accordance with the
Company’s regular payroll practices in effect from time to time. The Executive’s base salary and performance will
be reviewed by the Board on an annual basis and may be adjusted upward, but not downward, in the sole discretion of the Board
based on such review.

 

4.2
Bonus. During the term of this Agreement, Executive shall be eligible to receive an annual cash bonus in such amount (if
any) as may be approved of by the Board in its sole discretion.

 

    	 

    	 

    

 

4.3
Option Grant. On the Effective Date, Executive shall be awarded a stock option (the “Option”) to purchase
five hundred thousand (500,000) shares of the Company’s common stock, par value $0.001 per share (“Common Stock”),
at an exercise price equal to the closing market price of the Common Stock on the Effective Date. The Option shall be exercisable
for a 10-year period commencing on the Effective Date (subject to continued employment with the Company), and shall vest as to
(i) one-quarter of such shares on the Effective Date, (ii) an additional one-quarter of such shares on the one-year anniversary
of the Effective Date, (iii) an additional one-quarter of such shares on the two-year anniversary of the Effective Date, and (iv)
the remaining one-quarter of such shares on the three-year anniversary of the Effective Date.

 

4.4
Employee Benefits. Executive shall be entitled to participate in and be provided with such benefit plans and programs offered
to and or made available to the Company’s employees from time to time. In addition, Executive shall be entitled to paid
holidays in accordance with the Company’s regular policy and twenty days of vacation in each calendar year and reasonable
absences for illness. Any vacation time not taken during any calendar year of employment shall not be carried into any subsequent
calendar year, and the Company shall not be obligated to pay Executive for any vacation time available to but not used by Executive
within the prescribed period.

 

4.5
Expense Reimbursement. During the period of employment pursuant to this Agreement, Executive will be reimbursed for reasonable
expenses incurred for the benefit of the Company in accordance with the general policy of the Company which are approved in advance
by the Company and for which the Executive provides the Company with appropriate receipts and other documentation.

 

4.6
Deductions. All references herein to compensation to be paid to Executive are to the gross amounts thereof which are due
hereunder. The Company shall have the right to deduct therefrom all taxes which may be required to be deducted or withheld under
any provision of the law (including, without limitation, social security payments, income tax withholding and any other deduction
required by law) now in effect or which may become effective at any time during the term of this Agreement.

 

5.
Term; Severance.

 

5.1
Term. This Agreement shall be for an initial period of one year beginning on the Effective Date (the “Initial
Term”), and shall automatically continue following the Initial Term for successive periods of one year unless either
the Executive or the Company delivers a written notice of termination to the other party at least 30 days prior to the start of
any such renewal period (as so extended, the “Term”).

 

5.2
Severance. In the event that (a) the Company terminates Executive’s employment under this Agreement for any reason
other than (i) for “Cause” under Section 7, or (ii) Executive’s death or Disability, or (b) Executive terminates
his employment under this Agreement for Good Reason (as defined below), Executive shall be entitled to receive severance payments
consisting of continuing payments of Executive’s then monthly base salary under Section 4.1 for the lesser of (a) six-months,
and (b) the remainder of the Term; provided in each case Executive is then in compliance with his obligations under Section 8
of this Agreement.

 

    	2

    	 

    

 

5.3
Good Reason. For the purposes hereof, “Good Reason” shall mean the occurrence of any of the following
events without Executive’s consent: (i) a material reduction in Executive’s base salary below that provided for under
Section 4.1, (ii) the termination or material reduction of any material employee benefit or perquisite enjoyed by the Executive
(other than in connection with the termination or reduction of such benefit or perquisite to all executives of the Company or
as may be required by law), or (iii) the Company relocates its offices outside of the greater Las Vegas metropolitan area requiring
Executive to relocate his primary residence in order to perform his duties and responsibilities described herein. Notwithstanding
the foregoing, following written notice from the Executive of any of the events described above, the Company shall have thirty
(30) calendar days in which to cure the alleged conduct. If the Company fails to cure, the Executive’s termination shall
become effective on the 31st calendar day following such written notice.

 

5.4
Disability. For the purposes hereof, “Disability” shall mean the Executive becomes incapacitated or
disabled so as to be unable (either mentally or physically) to substantially perform the services required of Executive pursuant
to this Agreement for a period of ninety (90) or more consecutive days, or one hundred and twenty (120) or more non-consecutive
days, in any twelve (12) month period.

 

6.
Termination for Cause. The Company may discharge Executive at any time for Cause or upon Executive’s death or Disability
(subject to applicable legal requirements). For purposes of this Agreement, “Cause” means (a) gross negligence
or willful and serious misconduct, that is, or could reasonably be expected to be, injurious to the operations, financial condition,
or business reputation of the Company or its subsidiaries, (b) repeated or prolonged absence from work during normal business
hours for reasons other than disability or leave of absence approved by the Company, (c) conviction of a felony offense involving
moral turpitude, (d) commission of fraud or dishonesty in connection with the Company’s business, (e) a material breach
of any other provision of this Agreement or willful violation of any express direction or any reasonable rule or regulation established
by the Board from time to time, after, in each case under this clause (e) which is capable of curing, written notice is provided
to Executive and Executive has failed to cure such acts or action after a period of ten (10) days. In the event of any termination
pursuant to this Section 6, the Company shall have no further obligations or liabilities hereunder after the date of such discharge
(other than as set forth in Section 7.1 below).

 

7.
Consequences Upon Termination.

 

7.1
Payment of Compensation Owed. Upon the termination of Executive’s employment and this Agreement for any reason whatsoever,
the Company shall promptly pay to Executive all compensation owed to Executive up until the date of termination.

 

7.2
Return of Property. Upon the termination of Executive’s employment and this Agreement for any reason whatsoever,
Executive shall promptly return to the Company all Confidential Materials (as defined below) in his possession or within Executive’s
control, all keys, credit cards, business card files and other property belonging to the Company.

 

    	3

    	 

    

 

8.
Nondisclosure and Non-Compete.

 

8.1
Definitions. The following terms used in this Agreement shall have the respective meanings hereby assigned to them as follows:

 

(a)
“Customer” means any past or current customer of the Company or any of its subsidiaries and shall also include
those prospective customers who are actively being marketed by the Company or any of its subsidiaries during the term of this
Agreement.

 

(b)
“Competitor” means any individual, partnership, corporation, association or other business enterprise in any
form, other than the Company and its subsidiaries, which at any time during the Restriction Period, either directly or indirectly
engages in the business of (i) testing cannabis (including hemp) or products derived from cannabis, or (ii) providing any predictive,
molecular or genomic tools or similar services relating to the cultivation or processing of cannabis or cannabis products.

 

(c)
“Confidential Information” means all information of the Company and its subsidiaries which is not generally
known or available to the public or a Competitor (whether or not in written or tangible form), the knowledge of which could benefit
a Competitor, including without limitation, all of the following types of information:

 

	 	(i)	information
    pertaining to Customers or Personnel;
	 	 	 
	 	(ii)	research,
    projections, financial information, and cost and pricing information;
	 	 	 
	 	(iii)	product
    or service development plans and marketing strategies; and
	 	 	 
	 	(iv)	agricultural
    testing and analysis methods, trade secrets, or other knowledge or processes of or developed by the Company or any of its
    subsidiaries.

 

(d)
“Confidential Materials” means any and all documents, materials, programs, recordings or any other tangible
media (including, without limitation, copies or reproductions of any of the foregoing) in which Confidential Information may be
contained.

 

(e)
“Personnel” means any and all employees, contractors, agents, brokers, consultants or other individuals rendering
services to the Company or any of its subsidiaries for compensation in any form, whether employed by or independent of the Company
or any of its subsidiaries.

 

(f)
“Restriction Period” shall mean and refer to the period of time, commencing on Executive’s date of employment
and expiring two years after, for any reason whatsoever, the employment relationship between Executive and the Company or any
of its subsidiaries terminates.

 

    	4

    	 

    

 

8.2
Covenant Not to Compete.

 

(a)
During the Restriction Period, Executive shall not directly or indirectly, own, manage, invest or acquire any economic stake or
interest in, or otherwise engage or participate in any manner whatsoever in any Competitor (whether as a proprietor, partner,
shareholder, investor, manager, director, officer, employee, venturer, representative, agent, broker, independent contractor,
consultant, or other participant). Executive, however, shall not be prohibited from owning a passive investment of less than two
percent (2%) of the outstanding shares of capital stock or bonds of a corporation, which stock or bonds are listed on a national
securities exchange or are publicly traded in the over-the-counter market.

 

(b)
The parties recognize the possibility that there might be some limited ways, which the parties do not now contemplate, through
which Executive might be able to participate in a Competitor, and which pose no risk of harm to the interests of the Company or
its subsidiaries. If, prior to beginning any such relationship with a Competitor, Executive makes a full disclosure to the Company
of the nature of Executive’s proposed participation, the Company agrees to evaluate whether it or its subsidiaries will
suffer any risk of harm to it or their respective interests, and will notify Executive if it has any objection to Executive’s
proposed participation.

 

8.3
Covenant Not to Interfere.

 

(a)
During the Restriction Period, Executive shall not, directly or indirectly, solicit, induce or influence, or attempt to induce
or influence, any Customer to terminate a relationship which has been formed or that Executive knows is being formed with the
Company or any of its subsidiaries, or to reduce the extent of, discourage the development of, or otherwise harm its relationship
with the Company or any of its subsidiaries, including, without limitation, to commence or increase its relationship with any
Competitor.

 

(b)
During the Restriction Period, Executive shall not, other than during the term of this Agreement consistent with his duties and
obligations under Section 2 hereof, directly or indirectly, recruit, solicit, induce or influence, any Personnel known by Executive
to be employed by the Company or any of its subsidiaries to discontinue, reduce the extent of, discourage the development of,
or otherwise harm their relationship or commitment to the Company or its subsidiaries, including, without limitation, by employing,
seeking to employ or inducing or influencing a Competitor to employ or seek to employ any Personnel of the Company or any of its
subsidiaries, or inducing an employee of the Company or any of its subsidiaries to leave employment by the Company or its subsidiary,
as the case may be. Any general solicitation to the public that is not directed at the Company and/or any of its subsidiaries
shall not constitute a breach of this paragraph, and the restrictions set forth herein shall not apply to any person (i) who initiates
contact with Executive or Executive’s then current employer in response to a general solicitation to the public, or (ii)
who initiates contact with Executive or Executive’s then current employer in response to any general search conducted by
a placement firm which does not expressly target such Personnel.

 

    	5

    	 

    

 

8.4
Confidential Information.

 

(a)
Duty to Maintain Confidentiality. Executive shall maintain in strict confidence and safeguard all Confidential Information.
Executive covenants that Executive will become familiar with and abide by all policies and rules issued by the Company now or
in the future dealing with Confidential Information.

 

(b)
Covenant Not to Disclose, Use or Exploit. Executive shall not, directly or indirectly, disclose to anyone or use or otherwise
exploit for the benefit of anyone, other than the Company and its subsidiaries, any Confidential Information.

 

(c)
Confidential Materials. All Confidential Materials are and shall remain the exclusive property of the Company. No Confidential
Materials may be copied or otherwise reproduced, removed from the premises of the Company, or entrusted to any person or entity
(other than the Personnel entitled to such materials by authorization of the Company) without prior written permission from the
Company. Notwithstanding the foregoing, Executive may copy Confidential Information and remove such Confidential Information from
the Company’s premises to Executive’s residence, in each case, in the ordinary course of business in the discharge
of Executive’s duties and obligations under this Agreement.

 

8.5
Company Property. Any and all writings, improvements, processes, procedures and/or techniques which Executive may make,
conceive, discover or develop, either solely or jointly with any other person or persons, at any time during the term of this
Agreement, whether during working hours or at any other time and whether at request or upon the suggestion of the Company or any
subsidiary thereof, which relate to any business now or hereafter carried on or contemplated by the Company or any subsidiary
thereof, including developments or expansions of its present fields of operations, shall be the sole and exclusive property of
the Company. Executive shall make full disclosure to the Company of all such writings, improvements, processes, procedures and
techniques, and shall do everything necessary or desirable to vest the absolute title thereto in the Company. Executive shall
not be entitled to any additional or special compensation or reimbursement regarding any and all such writings, improvements,
processes, procedures and techniques.

 

9.
Remedies.

 

9.1
Equitable Relief. The parties acknowledge that the provisions and restrictions of Section 8 of this Agreement are reasonable
and necessary for the protection of the legitimate interests of the Company and Executive. The parties further acknowledge that
the provisions and restrictions of Section 8 of this Agreement are unique, and that any breach or threatened breach of any of
these provisions or restrictions by Executive will provide the Company with no adequate remedy at law, and the result will be
irreparable harm to the Company. Therefore, the parties agree that upon a breach or threatened breach of the provisions or restrictions
of Section 8 of this Agreement by Executive, the Company shall be entitled, in addition to any other remedies which may be available
to it, to institute and maintain proceedings at law or in equity, to recover damages, obtain specific performance or a temporary
or permanent injunction, without the necessity of establishing the likelihood of irreparable injury or proving damages and without
being required to post bond or other security.

 

    	6

    	 

    

 

9.2
Modification of Restrictions; Full Restriction Period. If the Restriction Period, the restriction area or the scope of
activity restricted in Article 8 should be adjudged unreasonable in any proceeding, then the Restriction Period shall be reduced
by such number of months, the restriction area shall be reduced by the elimination of such portion thereof or the scope of the
restricted activity shall be modified, or any or all of the foregoing, so that such restrictions may be enforced in such area
and for such time as is adjudged to be reasonable. If Executive violates any of the restrictions contained in Article 8, the Restriction
Period shall not run in favor of Executive from the time of commencement of any such violation until such time as such violation
shall be cured by Executive to the reasonable satisfaction of the Company.

 

10.
Consideration for Restrictive Covenants. Executive acknowledges that the execution of this Agreement and compliance with
it by the Company shall constitute fair and adequate consideration for Executive’s compliance with the restrictive covenants
contained in the respective sections of this Agreement.

 

11.
Miscellaneous.

 

11.1
Governing Law. This Agreement, its interpretation, performance and enforcement, and the rights and remedies of the parties
hereto, shall be governed and construed by the laws of the State of Nevada applicable to contracts to be performed wholly within
Nevada, without regard to principles of conflicts of laws and without the aid of any canon, custom or rule of law requiring construction
against the drafter.

 

11.2
Waiver. A waiver by any party of any condition or the breach of any term, covenant, representation or warranty contained
in this Agreement, whether by conduct or otherwise, in any one or more instances, shall not be deemed or construed as a further
or continuing waiver of any such condition or the breach of any other term, covenant, representation, or warranty set forth in
this Agreement.

 

11.3
Entire Agreement. This Agreement contains the entire agreement between the parties hereto with respect to the subject matter
hereof and supersedes all prior agreements and contemporaneous understandings, inducements or conditions, express or implied,
written or oral, between the parties with respect to the subject matter hereof. The express terms hereof control and supersede
any course of performance and/or usage of the trade inconsistent with any of the terms hereof.

 

11.4
Notices. All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given
or made (and shall be deemed to have been duly given or made upon receipt) by delivery in person, by courier service, by telecopy
or by registered or certified mail (postage prepaid, return receipt requested) to the respective parties at their addresses set
forth in the preamble to this Agreement (or at such other address for a party as shall be specified in a notice given in accordance
with this Section 11.4).

 

11.5
Headings. The descriptive headings contained in this Agreement are for convenience of reference only and shall not affect
in any way the meaning or interpretation of this Agreement.

 

    	7

    	 

    

 

11.6
Severability. If any term or other provision of this Agreement is invalid, illegal or incapable of being enforced by any
law or public policy, all other terms and provisions of this Agreement shall nevertheless remain in full force and effect so long
as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to
any party. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties
hereto shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as
possible in an acceptable manner in order that the transactions contemplated hereby are consummated as originally contemplated
to the greatest extent possible.

 

11.7
Counterparts. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate
counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one
and the same agreement.

 

11.8
Amendment or Termination. No agreement shall be effective to change, modify, waive, release, amend or terminate this Agreement,
in whole or in part, unless such agreement is in writing, refers expressly to this Agreement and is signed by the party against
whom enforcement of the change, modification, waiver, release, amendment or termination is sought.

 

11.9
Code Section 409A.

 

(a)
This Agreement shall be interpreted and administered in a manner so that any amount or benefit payable hereunder shall be paid
or provided in a manner that is either exempt from or compliant with the requirements of Section 409A of the Internal Revenue
Code of 1986, as amended (the “Code”) and applicable Internal Revenue Service guidance and Treasury Regulations
issued thereunder (and any applicable transition relief under Section 409A of the Code). Nevertheless, the tax treatment of the
benefits provided under the Agreement is not warranted or guaranteed. Neither the Company nor its directors, officers, employees
or advisers shall be held liable for any taxes, interest, penalties or other monetary amounts owed by Executive as a result of
the application of Section 409A of the Code.

 

(b)
Notwithstanding anything in this Agreement to the contrary, to the extent that any amount or benefit that would constitute non-exempt
“deferred compensation” for purposes of Section 409A of the Code (“Non-Exempt Deferred Compensation”)
would otherwise be payable or distributable hereunder, or a different form of payment of such Non-Exempt Deferred Compensation
would be effected, by reason of Executive’s termination of employment, such Non-Exempt Deferred Compensation will not be
payable or distributable to Executive, and/or such different form of payment will not be effected, by reason of such circumstance
unless the circumstances giving rise to such termination of employment meet any description or definition of “separation
from service” in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions that
may be available under such definition). This provision does not affect the dollar amount or prohibit the vesting of any
Non-Exempt Deferred Compensation upon a termination of employment. If this provision prevents the payment or distribution of any
Non-Exempt Deferred Compensation, or the application of a different form of payment, such payment or distribution shall be made
at the time and in the form that would have applied absent the non-409A-conforming event.

 

    	8

    	 

    

 

(c)
Notwithstanding anything in this Agreement to the contrary, if any amount or benefit that would constitute Non-Exempt Deferred
Compensation would otherwise be payable or distributable under this Agreement by reason of Executive’s separation from service
during a period in which he is a Specified Employee (as defined below), then, subject to any permissible acceleration of payment
by the Company under Treas. Reg. Section 1.409A-3(j)(4)(ii) (domestic relations order), (j)(4)(iii) (conflicts of interest), or
(j)(4)(vi) (payment of employment taxes): (i) the amount of such Non-Exempt Deferred Compensation that would otherwise be payable
during the six-month period immediately following Executive’s separation from service will be accumulated through and paid
or provided on the first day of the seventh month following Executive’s separation from service (or, if Executive dies during
such period, within 30 days after Executive’s death) (in either case, the “Required Delay Period”); and
(ii) the normal payment or distribution schedule for any remaining payments or distributions will resume at the end of the Required
Delay Period. For purposes of this Agreement, the term “Specified Employee” has the meaning given such term
in Code Section 409A and the final regulations thereunder.

 

(d)
Each payment of termination benefits under Section 5.2(a) of this Agreement shall be considered a separate payment, as described
in Treas. Reg. Section 1.409A-2(b)(2), for purposes of Section 409A of the Code.

 

(e)
If Executive is entitled to be reimbursed for any taxable expenses under Section 4.5 hereof, and such reimbursements are includible
in Executive’s federal gross taxable income, the amount of such expenses reimbursable in any one calendar year shall not
affect the amount reimbursable in any other calendar year, and the reimbursement of an eligible expense must be made no later
than December 31 of the year after the year in which the expense was incurred. No right of Executive to reimbursement of expenses
under Section 4.5 6 hereof shall be subject to liquidation or exchange for another benefit.

 

(f)
The Company shall have the sole authority to make any accelerated distribution permissible under Treas. Reg. Section 1.409A-3(j)(4)
to Executive of deferred amounts, provided that such distribution meets the requirements of Treas. Reg. Section 1.409A-3(j)(4).

 

    	9

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above.

 

	 	DIGIPATH,
    INC.
	 	 	 
	 	By	/s/
    Todd Peterson
	 	Name:	Todd
    Peterson
	 	Title:	Chief
    Financial Officer
	 	 
	 	/s/
    Kyle Remenda
	 	Kyle
    Remenda

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00300-of-00352.parquet"}]]